HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

HCA

HCA Healthcare, Inc. (S&P 500)

Healthcare — Medical Care Facilities

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Buy 2.0 / 5 22 analysts
$423.39
$-3.35 (-0.79%)
Target: $454.23 (7.3%)

Price History

52-Week Range
Sign in to add HCA to a watchlist or set price alerts.

Fundamentals

Market Cap$91.66B
P/E Ratio (TTM)14.19
Forward P/E13.22
EPS (TTM)$29.83
Dividend Yield0.73%
Profit Margin8.77%
Revenue Growth8.70%
ROE-
Debt/Equity-
Recommendation Buy 2.0
Analyst Target$454.23
Analysts22
Next Earnings Oct 27, 2026 BMO
Indexes S&P 500

Technical Indicators

RSI (14)47.3
Beta1.11
SMA 20$424.84
SMA 40$419.68
52-Week High$556.52
52-Week Low$353.99
50-Day Avg$414.51
200-Day Avg$446.51
Avg Volume$1.50M
Volume$1.10M

Performance Analysis

BULLISH

HCA shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 34% of its 52-week range.
~ RSI at 47.3 is in neutral territory.
+ P/E of 14.2 suggests the stock may be undervalued.
~ Modest revenue growth of 8.7% year-over-year.
+ Wall Street consensus is "Buy" from 22 analysts.
+ Average analyst target of $454.23 implies 7.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report